Thunderclap Research
Subscriber Login
Search
  • Publications
    • Tim Melvin’s Investment Advisory
    • Tim Melvin’s Takeover Targets
  • About
    • About Us
    • Tim Melvin
    • Garrett Baldwin
  • Commentary
  • SPAC Investing
  • Education Center
  • Subscriber Login
Sign Up

Commentary

Commentary

A Guaranteed, 100% Accurate Prediction of What Will Happen to the Market in 2021

Commentary |

Tim Melvin |

December 18, 2020

Around this time every year, we would start to see the prediction machine humming.  Talking heads on CNBC and all over Twitter start espousing what they think is going to happen going into the next year.  This year though, the…

Learn more

Commentary, SPACs

Calculated Risk: How to Invest in 2021

Commentary |

Tim Melvin |

December 14, 2020

It has been a hell of a year for IPOs.  Last week we saw DoorDash (DASH) fly, closing the day up 86% from its IPO price of $102. Airbnb followed the next day with its own very impressive first-day move….

Learn more

Commentary, SPACs

Another SPAC Arbitrage Trade… at a Discount

Commentary |

Tim Melvin |

November 24, 2020

Let’s be honest, the best market analyst of 2020 has been Dave “Davey Day Trader” Portnoy of Barstool Sports.  He has insisted that “stocks only go up” and has continuously made bets on garbage stocks that move higher, largely thanks…

Learn more

Market Updates

Dow Futures Rallies Higher After Pfizer Announces Final Results of Drug Trial

Market Updates |

Garrett Baldwin |

November 18, 2020

Good morning. Dow Jones futures today were pushing higher this morning after Pfizer reported 95% efficacy on its latest COVID-19 vaccine. That figure suggests that the new vaccine is more successful than previous data noted. The Dow Futures added another…

Learn more

Market Updates

The Great Rotation Continues on Vaccine News; Elon Musk Becomes World’s No. 3 Richest Person

Market Updates |

Garrett Baldwin |

November 17, 2020

The Dow Jones slumped more than 160 points in premarket hours as investors continued to rotate from growth stocks into more cyclical stocks. Recent announcements by Pfizer (PFE) and Moderna (MRNA) on their new vaccines has given investors optimism that…

Learn more

Market Updates

Stock Futures Flat as Investors Weigh Vaccine Timing, Risks of New Shutdowns

Market Updates |

Garrett Baldwin |

November 13, 2020

The Dow Jones today was off 64 points in pre-market hours as investors digest the latest rounds of earnings reports and COVID updates. Let’s take a look at the numbers from Thursday before we get into the headlines driving the…

Learn more

Market Updates

Dow Continues Breakout Rally After Pfizer Vaccine News

Market Updates |

Garrett Baldwin |

November 10, 2020

The Dow Jones today is up another 200 points in premarket hours. Investors continue to cheer a day after Pfizer (PFE) announced that it has developed a COVID vaccine with 90% efficacy. Yesterday’s announcement sent the Dow up more than…

Learn more
<...234...>

Subscribe to Thunderclap Research for FREE

Receive wealth-building advice delivered straight to your inbox.

Market Updates

  • Dow Futures Rallies Higher After Pfizer Announces Final Results of Drug Trial

    November 18, 2020
  • The Great Rotation Continues on Vaccine News; Elon Musk Becomes World’s No. 3 Richest Person

    November 17, 2020
  • Stock Futures Flat as Investors Weigh Vaccine Timing, Risks of New Shutdowns

    November 13, 2020

Premium Services

Tim Melvin’s Investment Advisory >>

Tim Melvin’s Takeover Targets >>

Thunderclap Research

© 2021 Thunderclap Research. All rights reserved

Publications

  • Tim Melvin’s Investment Advisory
  • Tim Melvin’s Takeover Targets

Our Team

  • Tim Melvin
  • Garrett Baldwin

About Us

  • Contact
  • About Us
  • FAQ
  • Privacy Policy
  • Terms of Use

Subscribe

Sign Up